The US Sun

A SINGLE-dose nasal spray treatment could 'wash away' build ups of toxic proteins associated with Alzheimer’s disease from brain cells and improve memory, scientists say. The study - performed on mice - paves the way for new treatments against Alzheimer's and dementia, researchers at the University of Texas Medical Branch said.

Single-dose nasal spray ‘washes the brain’ of toxic Alzheimer’s proteins – paving the way for breakthrough treatment

I’ve always adored cinnamon. Its aroma warms the cockles of my heart, and its flavor makes me feel as if I’m wrapped up in an old fairy tale. However, I was floored when I reviewed some of the latest research regarding the effects of cinnamon on brain health.

Cinnamon versus brain cancer, Alzheimer’s disease, and insomnia

Minnesota State

Fox News

Scientists at Mayo Clinic say they have identified a new type of memory loss that is very similar to Alzheimer’s disease, but doesn’t progress as quickly and has a “better prognosis."

Mayo Clinic finds new type of memory loss that’s often mistaken for Alzheimer’s

Blood tests that can detect 90% of Alzheimer’s cases could revolutionize access to Alzheimer’s treatment, studies say.

Alzheimer’s blood test catches 90% of early dementia cases, study finds

A DAD-OF-FIVE died after mistakenly pouring washing detergent on a bowl of cornflakes instead of milk, an inquest has heard. Tom McDonald was rushed to St Vincent’s University Hospital (SVUH) in Dublin on March 9, 2023, after his daughter realised he had accidentally poisoned himself. “It was so quick – he was perfectly well and […]

Dad-of-five with dementia died after accidentally pouring washing detergent on his cornflakes instead of milk

DEMENTIA is sometimes called “the long goodbye”.  This is because although the person is still alive, the brain-eating condition slowly chips away at their memories and the qualities that make them “them”. The disease affects about a million Brits and is the UK’s top cause of death. Hospice nurse, Julie McFadden, 41, is now sharing […]

End-of-life nurse reveals what dying from dementia is really like – and how to spot a ‘staircase decline’

Health Digest

The first signs of cognitive decline in an older relative could hint at a condition called dementia. One form, Alzheimer's dementia, manifests in 7 stages.

The 7 Stages Of Dementia Before Death Explained

Community Voices represent independent, third-party users who have joined our contributor program but not yet verified their accounts. Community Voices are expected, like all users, to adhere to our Community Standards.

community_voice

Herbie J Pilato

Actor Buddy Ebsen, who died at age 95 in 2003, found fame by starring in two of the most popular classic television shows in history: The Beverly Hillbillies (CBS, 1962 to 1971) and Barnaby Jones (CBS, 1973 to 1980). On the Hillbillies, he played former Tennessee country mountain-folk-turned-wealthy Beverly Hills resident Jed Clampett. On Barnaby Jones, he was one of TV's most senior, slyest, health-conscious detectives. Ebsen, however, almost became even more famous for a certain big-screen classic film in which he ultimately did not appear.

'Beverly Hillbillies" Actor Buddy Ebsen Was "Bitter" about not playing the Tin Man in 'Wizard of Oz'

Kansas City, MO

Kentucky Vibes.net

Disclaimer: This article was written with the help of A.I. software. Kansas City Chiefs quarterback Patrick Mahomes, known for his prowess on the football field, made a personal announcement during a press conference on Tuesday. The three-time Super Bowl champion revealed that he and his wife, Brittany Mahomes, are expecting their third child and that this will be their last.

Patrick Mahomes Reveals He's 'Done' Having Kids with Wife Brittany Mahomes After Baby No. 3

Two recent developments in Alzheimer’s disease research offer new hope for patients living with the disease, and their families. Among those, in June, Tiziana Life Sciences received Food and Drug Administration clearance to use intranasal foralumab in its first patient with moderate Alzheimer’s disease under the FDA’s expanded access investigational new drug program.

FDA clears nasal spray for moderate Alzheimer’s disease in first patient

Philadelphia, PA

Parade

Find out what dementia experts have to say about the connection.

A New Study Says This Commonly-Prescribed Medication Could Help Lower Dementia Risk By 50%

It's natural to experience some cognitive decline as we age, but not all cognitive deficits are a result of dementia. There are a variety of hormonal conditions and nutrient deficiencies that can present similar symptoms. If you’re having trouble concentrating or experiencing some memory loss, don’t panic just yet—rule out...

3 Conditions That Cause Cognitive Decline (But Aren't Dementia)

In the intricate architecture of​ the human ⁢brain, the emergence of Alzheimer’s disease often heralds a disheartening reality: a gradual and relentless‌ dismantling of memory,⁣ cognition, and identity. Yet, ⁣amidst ‌the shadows ‍cast by this formidable condition, ‍a new ray of ⁤hope has surfaced from the⁣ depths of‍ neuroscience research. ‌Recent studies are unveiling the intriguing relationship between dopamine—a neurotransmitter central to our ⁤feelings ‌of pleasure and reward—and the notorious brain plaques that characterize ‍Alzheimer’s. The idea​ that‍ this chemical messenger ‌could play a‍ pivotal role in dissolving harmful amyloid-beta plaques not only sparks ⁣curiosity but⁢ ignites a potential breakthrough in our understanding of neurodegenerative diseases. In this exploration, ​we delve⁢ into the science ‍behind dopamine’s unexpected therapeutic promise and the implications it holds for combating one ⁣of humanity’s most pressing health⁤ challenges. Join us as we unravel the layers of this complex puzzle, highlighting a⁣ path that may lead to a future where Alzheimer’s is no longer a looming specter but a challenge​ we can confidently confront.

Melting Away Alzheimer’s: How Dopamine Dissolves Harmful Brain Plaques

Visual hallucinations are a significant issue for many patients with Parkinson’s disease. A recent study published in the journal Brain reveals that these hallucinations are associated with a marked deficiency of cholinergic activity in specific regions of the brain, particularly the left ventral visual stream and the left superior temporal lobe. This research highlights the importance of cholinergic denervation in visual hallucinations, offering new insights into the underlying mechanisms and potential treatment options.

Visual hallucinations in Parkinson’s disease linked to cholinergic deficiency

Research indicates that getting too little or too much sleep in later life is associated with a higher risk of developing Alzheimer's disease. The earliest affected brain regions in Alzheimer's are those involved in regulating sleep and circadian rhythms. This means that individuals in the early stages of the condition might experience sleep disturbances before showing the typical signs of memory loss or other symptoms.

Research States That Poor Sleeping Patterns In Older Adults Lead To Increased Risk Of Dementia

Neurology News Network. for the week ending August 3, 2024. [WATCH TIME: 4 minutes]. Welcome to this special edition of Neurology News Network. I'm Marco Meglio. According to an announcement, the FDA has approved Alpha Cognition’s ALPHA-1062 (Zunveyl), a prodrug of an approved AChE inhibitor, galantamine, as a treatment for patients with mild-to-moderate Alzheimer disease (AD). ALPHA-1062, a delayed-release oral tablet formulation, is considered a new-generation AChEI inhibitor, with expected minimal gastrointestinal adverse events. The approval was based on results from 4 studies demonstrating the bioequivalence of ALPHA-1062 to galantamine and galantamine extended-release (ER). Across those studies, only 2% of treated patients had AEs from treatment, with no cases of insomnia observed. ALPHA-1062 is absorbed in the small intestine as an insert drug. Binding with AChE in the gastrointestinal nervous system is blocked by the addition of a benzyl ester to galantamine.

ALPHA-1062 Approved for Alzheimer Disease, GLP-1 Agonist Shows Neuroprotective Effects Against Dementia, Lecanemab 3-Year Data Reported

A recent study published in the International Journal of Geriatric Psychiatry reveals a significant link between depression and an increased risk of developing dementia. Conducted over 15 years, the study found that people with depression at the start of the study were 74% more likely to develop dementia than those without depression. Additionally, the onset of dementia occurred about two years earlier in individuals with depression. These findings underscore the importance of early detection and treatment of depression to potentially prevent future cognitive decline.

This common mental health condition increases the risk of dementia by 74%, study finds

Chicago, IL

Writers represent independent, third-party users who have joined our contributor program and self-verified their accounts. Writers are expected, like all users, to adhere to our Community Standards.

writer

Foodie in Chicago

Shortly before 3 AM, people in the Chicago area may have felt their houses shake as a 3.4-magnitude earthquake occurred about 60 miles west of the city. (CHICAGO) The United States Geological Survey (USGS) reported a 3.4-magnitude earthquake around Somonauk, IL. Somonauk is in DeKalb and LaSalle Counties, 64 miles west of Chicago.

Did You Feel the Earthquake?

shefinds

Parkinson’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide. Characterized by tremors, stiffness, and difficulty with balance and coordination, the disease is primarily caused by the loss of dopamine-prod...

3 Supplements A Neuroscientist Swears By To Prevent Parkinson’s Disease: ‘Gives Your Brain The Raw Materials To Repair Itself’

Health

Medically reviewed by Brigid Dwyer, MDMedically reviewed by Brigid Dwyer, MDDementia is a broad term that describes the loss of cognitive abilities like thinking, remembering, using language, and making decisions. Lewy body dementia (LBD) is one type of dementia, named after the scientist who discovered this variation. This type of dementia is thought to be caused by a buildup of a specific protein in the brain.  There are two types of LBD: dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD). In general, both types of LBD are caused by the same accumulation of protein in the brain and...

Signs and Symptoms of Lewy Body Dementia

NewsBreak

New Drug Restores Lost Alzheimer’s Memories in Mice

In mouse trials, researchers have discovered a molecule that they say can restore both cognition and even memories lost to Alzheimer's disease. In a press release...

New Drug Restores Lost Alzheimer’s Memories in Mice

Comments / 0